Provided by Tiger Trade Technology Pte. Ltd.

Abbott Laboratories

112.47
+0.88000.79%
Post-market: 112.480.0100+0.01%19:57 EDT
Volume:7.55M
Turnover:846.70M
Market Cap:195.57B
PE:36.39
High:112.75
Open:111.60
Low:111.11
Close:111.59
52wk High:137.49
52wk Low:81.97
Shares:1.74B
Float Shares:1.70B
Volume Ratio:0.98
T/O Rate:0.44%
Dividend:2.48
Dividend Rate:2.21%
EPS(TTM):3.09
EPS(LYR):3.73
ROE:10.58%
ROA:5.33%
PB:3.83
PE(LYR):30.15

Loading ...

FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar

Reuters
·
Aug 26

FDA :Granted Marketing Authorization to Abbott Diabetes Care for Libre Duo 10 Day Through De Novo Premarket Review Pathway

THOMSON REUTERS
·
Aug 26

Abbott Laboratories Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Analyst Raises Abbott Price Target to $135 on Strengthening Cancer Diagnostics Growth and Successful Exact Sciences Integration

TIPRANKS
·
Aug 21

Dow Jones Top Company Headlines at 9 am ET: Nvidia in Talks to Invest in Data-Center Power Developer Cloverleaf | Italy's ...

Dow Jones
·
Aug 21

Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Alvotech (ALVO) and Abbott Laboratories (ABT)

TIPRANKS
·
Aug 21

Wells Fargo Keeps Their Buy Rating on Abbott Laboratories (ABT)

TIPRANKS
·
Aug 21

TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating

MT Newswires Live
·
Aug 21

Analysts Have Conflicting Sentiments on These Healthcare Companies: Abbott Laboratories (ABT) and Doximity (DOCS)

TIPRANKS
·
Aug 21

U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions

Reuters
·
Aug 21

PRESS Digest-Wall Street Journal - August 21

Reuters
·
Aug 21

Abbott : TD Cowen Raises Target Price to $135 from $115

THOMSON REUTERS
·
Aug 21

Perrigo Co. PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 21

Abbott Reaches Agreements to Resolve Portion of Litigation over Infant Formula

Reuters
·
Aug 21

Abbott resolves portion of litigation regarding specialty infant formulas

TIPRANKS
·
Aug 21

Abbott Agrees to Settle Preterm Infant Formula NEC Lawsuits for About $670 Million

Reuters
·
Aug 21

Abbott Reaches Agreements to Resolve a Portion of Litigation Involving Its Specialty Formulas for Preterm Infants

THOMSON REUTERS
·
Aug 21

Abbott - to Pay About $670 Mln to Resolve Gill Case and Nec Claims

THOMSON REUTERS
·
Aug 21

Abbott - Reaches Agreements to Resolve Gill Case and 2,000 Related Claims

THOMSON REUTERS
·
Aug 21

Abbott - About 1,700 Lawsuits Remain Pending Involving Claims for 12,700 Infants

THOMSON REUTERS
·
Aug 21